Correlation Between Visa and Novozymes A/S
Can any of the company-specific risk be diversified away by investing in both Visa and Novozymes A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Novozymes A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Novozymes AS B, you can compare the effects of market volatilities on Visa and Novozymes A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Novozymes A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Novozymes A/S.
Diversification Opportunities for Visa and Novozymes A/S
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Novozymes is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Novozymes A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of Visa i.e., Visa and Novozymes A/S go up and down completely randomly.
Pair Corralation between Visa and Novozymes A/S
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.42 times more return on investment than Novozymes A/S. However, Visa Class A is 2.37 times less risky than Novozymes A/S. It trades about 0.28 of its potential returns per unit of risk. Novozymes AS B is currently generating about -0.13 per unit of risk. If you would invest 27,117 in Visa Class A on August 27, 2024 and sell it today you would earn a total of 3,875 from holding Visa Class A or generate 14.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. Novozymes AS B
Performance |
| Timeline |
| Visa Class A |
| Novozymes AS B |
Visa and Novozymes A/S Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Novozymes A/S
The main advantage of trading using opposite Visa and Novozymes A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Novozymes A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes A/S will offset losses from the drop in Novozymes A/S's long position.| Visa vs. American Express | Visa vs. Morningstar Unconstrained Allocation | Visa vs. Sitka Gold Corp | Visa vs. MSCI ACWI exAUCONSUMER |
| Novozymes A/S vs. First Graphene | Novozymes A/S vs. HUMANA INC | Novozymes A/S vs. Aquagold International | Novozymes A/S vs. Barloworld Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |